In the last few years the operation of hypophysectomy has been used in the treatment of certain types of general disease, particularly malignant disease and diabetes mellitus. This paper is concerned with the use of hypophysectomy and the destruction of the hypophysis by radiation in the treatment of malignant disease, the clinical aspects in outline only, and concentrates on the role of the chemical pathologist and clinical biochemist in the investigation and care of these patients.
Beatson (1896, made the pioneer observations on the control of malignant disease by hormones when he reported the treatment of carcinoma of the breast by removal of the ovaries. It is known that many tumours of the breast and the prostate are hormone-dependent, for their continued growth depends on the presence in the body of actively secreting gonads and adrenal cortex: the rationale of hypophysectomy is primarily the removal of the hypophyseal stimulation of these secretions. It has also been demonstrated that somatotrophin has a direct stimulant action on the growth of a tumour (Pearson, Ray, Harrold, West, Li, and Maclean, 1954) . Pearson and his colleagues administered somatotrophin to a patient who had had a hypophysectomy: the secondary deposits in bone extended, and regressed again when somatotrophin administration was stopped. There is also some evidence that luteotrophin has a directly stimulatory action on prostatic growth (Sonenberg, 1952; Scott, 1954; Sjogren, 1952; Luft, 1954a and b;  Luft, Olivecrona, Sjogren, Ikkos, and Ljunggren, 1955; . Their latest report Beau, Klotz, Sicard, and Clavel, 1952; Perrault, 1952; Le Beau and Perrault, 1953; St6rtebecker, 1954; Boulard, Descuns, Garre, and Gautray, 1954; Schutte, Picaza, Marinello, and Marquez. 1954; Pearson et al., 1954; Driesen, 1955) , and many large series are in progress both in this country and abroad, but no details have yet been published.
Fewer cases of carcinoma of the prostate have been treated by hypophysectomy Scott, 1954 Bierman, Ortega and Naffziger, 1952; .
Hypophysectomy has been performed, without apparent effect, for the treatment of malignant hypertension, hypernephroma, and chorion carcinoma , for adrenocortical carcinoma with Cushing's syndrome (Knowlton, Pool, and Jailer, 1954) and for seminoma (Gilbert-Dreyfus, Pertuiset, Savoie, and Sebaoun, 1954) . One indication for hypophysectomy which I consider reasonable, but of which we have had no experience, is for the treatment of malignant exophthalmos, in order to remove the hypophyseal exophthalmos-producing substance. Albeaux-Fernet, Guiot, Braun, Cauvin, and Romani (1955) have reported the treatment of one case of malignant exophthalmos by hypophysectomy. There was marked improvement for three months.
In the Royal Free Hospital 13 hypophysectomies have been performed between October, 1954, and July, 1955 , all for the treatment of carcinoma of the breast in women. The results, to October 1, 1955, are shown in Table I .
All these patients were under the care of Mr. E. J. Radley-Smith, who performed the hypophysectomies. Further details of these and other patients will be published in due course.
The results can be summarized as follows: Two patients (Nos. 2 and 13) died within 48 hours of the operation. Five patients (Nos. 1, 4, 5, 6, and 8) died within six months of the operation, some of them having had relief of pain for varying lengths of time after the operation. One patient (No. 7) is still alive, having had relief of pain but little objective slowing of the rate of growth of the tumour, and her prognosis is poor. Five patients (Nos. 3, 9, 10, 11, 12) have so far had complete relief of pain and a remarkable increase in their sense of well-being, usually with slowing of the rate of growth of the tumours, and in certain cases disappearance of local or distant metastases.
As it has been said (Luft and Olivecrona, 1955), "The number of patients and the time of observation is too small to give an answer to the question whether hypophysectomy offers patients with metastatic breast cancer anything further than bilateral adrenalectomy in combination with ovariectomy." Hypophysectomy has theoretical advantages over combined adrenalectomy and oophorectomy. It removes somatotrophin and luteotrophin and hormones from accessory adrenal glands, as well as the adrenal cortical hormones and gonadal hormones which are removed by the combined operation. 1926 1911 1927 1922 1908 1913 1914 1912 1897 1907 1901 1904 1902 Date cancer found .1952 1948 1954 1953 1951 1951 1951 1953 1950 1953 1954 1952 1954 Early treatment: Mastectomy/radiotherapy If it were possible to destroy the whole hypophysis, and only the hypophysis, by radiation, then the relief of malignant disease by hypophysectomy could be more widely practised. Various radioactive isotopes have been used. Bergenstal (1955) has used 5 mc. of 90Y, and Rothenberg has used 10 mc. of 32P (Rothenberg, Jaffe, Putnam, and Simkin, 1955) inserted directly into the pituitary fossa. After surgical hypophysectomy as a precautionary measure 7.5 mc. of 198Au is inserted, but the dose is to be increased. There is no definite evidence yet that these measures are successful. Forrest and Brown (1955) During the first 24 hours after the operation 500 ml. of physiological saline and 2,000 ml. of 5% glucose are infused. Noradrenaline and hydrocortisone (free alcohol) are kept available, to be put into the infusion, in case of a catastrophic postoperative fall in blood pressure.
The rate of reduction of cortisone to the maintenance dosage shown on the chart depends principally on the clinical response of the patient, though serial plasma sodium and potassium estimations should be performed. This is usually achieved in one to two weeks. The salt balance of the patients is easy to control because t e intact adrenal glands continue to secrete aldosterone, and it is planned to investigate any change in aldosterone secretion with time. The postadrenalectomy patients are much more difficult to control, and need more cortisone, presumably because aldosterone is missing. They are given extra salt.
The third problem is to assess whether hypophysectomy has been complete. The Swedish work suggests that if fragments of hypophysis are left they can grow again and maintain relatively normal endocrine status, and optimum results may not be obtained. Re-operation is possible within three weeks of the initial operation. Luft takes his patients off replacement therapy for two or three weeks before re-investigating adrenal function, but tnis procedure has not yet been used. Indeed, Pearson and his colleagues have reported the development of acute adrenal insufficiency within five days of withdrawing cortisone from a patient after complete hypophysectomy (West, Li, Maclean, Rall, and Pearson, 1954) . Amongst the methods that are being used are urine oestrogen and gonadotrophin estimations (but the difficulties here are to measure very small quantities), the eosinophil response to adrenaline , and studies of thyroid function and of cortisone withdrawal .
A method being tried is the differential urinary ketosteroid analysis: dehydroepiandrosterone is not a metabolite of the administered cortisone, and if found must have come from active adrenals. The estimation of plasma dehydroepiandrosterone may also be useful.
The response of water excretion to total hypophysectomy is of great interest, and has been studied in detail by the Stockholm team (Ikkos, Kettering Institute has shown that the polyuria, which develops in 60% of cases, is independent of whether hypophysectomy has been complete. Our results suggest that it is independent of the presence of intact adrenals. The cause of the oliguric interphase is also not known.
Summary
The use of hypophysectomy and of destruction of the hypophysis by radiation in the treatment of malignant disease is described. Of 13 female patients with carcinoma of the breast who had been operated on within a year, five had had a good result so far, with complete relief of pain and variable regression of the metastases.
The tasks of the chemical pathologist in the preoperative assessment of the patients (with particular regard to their adrenal function), in the biochemical control of the disturbances of metabolism, and in the difficult problem of assessing whether hypophysectomy has been complete, are discussed.
I am grateful to Mr. E. J. Radley-Smith for his advice and for permission to quote the clinical summaries: I would also like to thank Miss Irene Cade, surgical registrar, for allowing me to use her case notes.
